Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

Clinical trial NCT00088907 · TERMINATED

Trial details

NCT number: NCT00088907
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Metastatic Head and Neck Cancer

Start date: 2004-08-01
Primary completion: 2009-05-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.